半岛bd体育手机客户端 说明
一般描述
A potent, reversible, and selective inhibitor of cyclin-dependent kinases (Cdks) that exhibits about ten-fold greater efficacy towards p34cdk1and p33cdk2and twenty-fold greater efficacy towards p33cdk5relative to Olomoucine (Cat. No. 495620). Inhibits p34cdk1/cyclin B (IC50= 650 nM), p33cdk2/cyclin A (IC50= 700 nM), p33cdk2/cyclin E (IC50= 700 nM), and p33cdk5/p35 (IC50= 200 nM) by competing for the ATP binding domain of the kinases. Exhibits reduced sensitivity towards related kinases including ERK1 and ERK2 (IC50= 34 ?M and 14 ?M, respectively). Roscovitine does not significantly affect the activity of other protein kinases even at 100 ?M, including p34cdk4/cyclin D1 and p40cdk6/cyclin D2. Compared to olomoucine, roscovitine displays increased anti-mitotic activity at the G1/S and G2/M phases of the cell cycle. A 50 mM (5 mg/282 ?l) solution of Roscovitine (Cat. No. 557364) in DMSO is also available.
A potent, reversible, and selective inhibitor of cyclin-dependent kinases (cdks). Exhibits greater inhibitory potency compared to olomoucine (Cat. No. 495620). Inhibits p34cdc2/cyclin B (IC50= 0.65 ?M), p33cdk2/cyclin A (IC50= 0.70 ?M), p33cdk2/cyclin E (IC50= 0.70 ?M), and p33cdk5/p35 (IC50= 0.20 ?M) by competing for the ATP binding domain of these kinases. Exhibits very low sensitivity towards related kinases, such as erk1 and erk2 (IC50= 34 ?M and 14 ?M, respectively). Roscovitine does not significantly affect the activity of other protein kinases even at 100 ?M and compared to olomoucine, roscovitine displays increased anti-mitotic activity at the G1/S and G2/M phases of the cell cycle.
包装
1, 5 mg in Plastic ampoule
生化/生理作用
Primary Target
p34cdk1/cyclin B
Product does not compete with ATP.
Target IC50: 650 nM, 700 nM, 700 nM, 200 nM, against p34cdk1/cyclin B, p33cdk2/cyclin A, p33cdk2/cyclin E, p33cdk5/p35, respectively
Cell permeable: no
Reversible: yes
警告
Toxicity: Standard Handling (A)
重悬
Following reconstitution, aliquot and freeze (-20°C). DMSO stock solutions are stable for at least 6 months at -20°C.
其他说明
De Azevedo, W.F., et al. 1997.Eur. J. Biochem.243,518.
Meijer, L., et al. 1997.Eur. J. Biochem.243,527.
Meijer, L., et al. 1996.Trends Cell Biol.6,393.
Rudolph, B., et al. 1996.EMBO J.15,3053.
法律信息
Sold under license of U.S. Patent 6,316,456
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
基本信息
经验(实验)分子式 | C19H26N6O |
分子量 | 354.45 |
MDL编号 | MFCD02266401 |
半岛bd体育手机客户端 性质
质量水平 | 100 |
测定 | ≥95% (HPLC) |
形式 | solid |
manufacturer/tradename | Calbiochem? |
储存条件 | OK to freeze |
颜色 | white to off-white |
溶解性 | DMSO: 10 mg/mL |
运输 | ambient |
储存温度 | ?20℃ |
InChI | 1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1 |
InChI key | BTIHMVBBUGXLCJ-OAHLLOKOSA-N |
安全信息
储存分类代码 | 11 - Combustible Solids |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
Sigma-Aldrich